With more than 15 years of experience as a patent professional, Lasse Weinmann’s practice focuses on biotech and pharma cases. His areas of scientific expertise include therapeutic proteins such as antibodies and blood factors, CAR T-cells, diagnostic methods, sequencing technologies, vaccines, and small RNA-based drugs. Lasse represents both international and domestic clients, including major international biotech and pharma companies as well as domestic university clients and spin-off companies. He is frequently involved in German nullity proceedings, multinational invalidity and infringement disputes in close coordination with international litigation teams, as well as in EPO opposition/appeal cases. Lasse also provides opinion work to his clients, including FTO and invalidity opinions, and represents his clients in due diligence discussions with potential investors.

Whether an academic client, a spin-off company or a large biotech or pharma company, Lasse enjoys working with each client, with a keen understanding of the client’s needs, the technology involved, and the strategic framework, in order to identify the best solution for the client.